A detailed history of Vista Wealth Management Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Vista Wealth Management Group, LLC holds 3,188 shares of ABBV stock, worth $522,321. This represents 0.05% of its overall portfolio holdings.

Number of Shares
3,188
Previous 2,934 8.66%
Holding current value
$522,321
Previous $454,000 27.75%
% of portfolio
0.05%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$159.82 - $182.1 $40,594 - $46,253
254 Added 8.66%
3,188 $580,000
Q4 2023

Feb 12, 2024

SELL
$137.6 - $154.97 $66,598 - $75,005
-484 Reduced 14.16%
2,934 $454,000
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $71,337 - $82,583
534 Added 18.52%
3,418 $509,000
Q2 2023

Aug 02, 2023

SELL
$132.51 - $164.9 $5,167 - $6,431
-39 Reduced 1.33%
2,884 $388,000
Q1 2023

May 04, 2023

SELL
$144.61 - $166.54 $37,020 - $42,634
-256 Reduced 8.05%
2,923 $465,000
Q4 2022

Feb 07, 2023

BUY
$138.31 - $165.87 $73,580 - $88,242
532 Added 20.1%
3,179 $514,000
Q3 2022

Oct 25, 2022

SELL
$134.21 - $153.93 $81,062 - $92,973
-604 Reduced 18.58%
2,647 $399,000
Q2 2022

Jul 14, 2022

SELL
$137.62 - $174.96 $4,403 - $5,598
-32 Reduced 0.97%
3,251 $495,000
Q1 2022

May 04, 2022

SELL
$131.98 - $163.75 $94,497 - $117,245
-716 Reduced 17.9%
3,283 $532,000
Q4 2021

Jan 19, 2022

BUY
$107.43 - $135.93 $39,104 - $49,478
364 Added 10.01%
3,999 $541,000
Q3 2021

Nov 02, 2021

BUY
$106.4 - $120.78 $14,257 - $16,184
134 Added 3.83%
3,635 $392,000
Q2 2021

Jul 27, 2021

BUY
$105.21 - $117.21 $154,974 - $172,650
1,473 Added 72.63%
3,501 $394,000
Q1 2021

Apr 26, 2021

BUY
$102.3 - $112.62 $3,069 - $3,378
30 Added 1.5%
2,028 $219,000
Q4 2020

Jan 25, 2021

BUY
$80.49 - $108.67 $160,819 - $217,122
1,998 New
1,998 $214,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $290B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Vista Wealth Management Group, LLC Portfolio

Follow Vista Wealth Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vista Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vista Wealth Management Group, LLC with notifications on news.